N'-(3-((3,5-dimethylisoxazol-4-yl)methoxy)benzoyl)quinoline-2-carbohydrazide

ID: ALA5189566

PubChem CID: 29857166

Max Phase: Preclinical

Molecular Formula: C23H20N4O4

Molecular Weight: 416.44

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1noc(C)c1COc1cccc(C(=O)NNC(=O)c2ccc3ccccc3n2)c1

Standard InChI:  InChI=1S/C23H20N4O4/c1-14-19(15(2)31-27-14)13-30-18-8-5-7-17(12-18)22(28)25-26-23(29)21-11-10-16-6-3-4-9-20(16)24-21/h3-12H,13H2,1-2H3,(H,25,28)(H,26,29)

Standard InChI Key:  FXHULYSZTRWMRO-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 31 34  0  0  0  0  0  0  0  0999 V2000
    1.7992    3.9173    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7992    3.0923    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5126    2.6859    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2198    3.0960    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2198    3.9177    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5108    4.3279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0866    2.6814    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3719    3.0939    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3719    3.9148    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0815    4.3314    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3397    2.6831    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3397    1.8613    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0512    1.4504    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0512    0.6286    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7630    0.2177    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7630   -0.6040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4732   -1.0129    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1866   -0.6020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1866    0.2156    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4777    0.6304    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4732   -1.8348    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7615   -2.2456    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7615   -3.0674    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0971   -3.5501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3509   -4.3314    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1722   -4.3314    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4261   -3.5501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2198   -3.3374    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3033   -3.3374    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3397    0.2177    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0512    3.0939    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  1  2  0
  2  7  1  0
  8  7  2  0
  9  8  1  0
 10  9  2  0
  1 10  1  0
  8 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 16 15  2  0
 17 16  1  0
 18 17  2  0
 19 18  1  0
 20 19  2  0
 15 20  1  0
 17 21  1  0
 21 22  1  0
 22 23  1  0
 24 23  1  0
 24 25  2  0
 25 26  1  0
 27 26  1  0
 27 23  2  0
 27 28  1  0
 24 29  1  0
 14 30  2  0
 11 31  2  0
M  END

Associated Targets(Human)

PRMT5 Tchem PRMT5/MEP50 complex (963 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LNCaP (8286 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

COS-1 (266 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 416.44Molecular Weight (Monoisotopic): 416.1485AlogP: 3.49#Rotatable Bonds: 5
Polar Surface Area: 106.35Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 8.30CX Basic pKa: 1.65CX LogP: 2.89CX LogD: 2.85
Aromatic Rings: 4Heavy Atoms: 31QED Weighted: 0.48Np Likeness Score: -1.85

References

1. Asberry AM, Cai X, Deng X, Santiago U, Liu S, Sims HS, Liang W, Xu X, Wan J, Jiang W, Camacho CJ, Dai M, Hu CD..  (2022)  Discovery and Biological Characterization of PRMT5:MEP50 Protein-Protein Interaction Inhibitors.,  65  (20.0): [PMID:36206451] [10.1021/acs.jmedchem.2c01000]
2. Asberry AM, Cai X, Deng X, Santiago U, Liu S, Sims HS, Liang W, Xu X, Wan J, Jiang W, Camacho CJ, Dai M, Hu CD..  (2022)  Discovery and Biological Characterization of PRMT5:MEP50 Protein-Protein Interaction Inhibitors.,  65  (20.0): [PMID:36206451] [10.1021/acs.jmedchem.2c01000]

Source